We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
-11.58%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
–
AUM
$406M
AUM Growth
-$4.59M
Cap. Flow
+$56.2M
Cap. Flow %
13.85%
Top 10 Hldgs %
62.96%
Holding
28
New
–
Increased
11
Reduced
3
Closed
–

Top Buys

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$20.3M
2
NTRA icon
Natera
NTRA
+$14.2M
3
AMWL icon
American Well
AMWL
+$6.6M
4
CANO
Cano Health, Inc.
CANO
+$6.35M
5
DXCM icon
DexCom
DXCM
+$5.34M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$9.95M
2
BPMC
Blueprint Medicines
BPMC
+$1.59M
3
HUM icon
Humana
HUM
+$305K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCCC icon
26
C4 Therapeutics
CCCC
$476M
$1.15M 0.28%
47,200
– –
OLK
27
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$706K 0.17%
40,000
– –
LYEL icon
28
Lyell Immunopharma
LYEL
$365M
$505K 0.12%
5,000
– –
1
2

Similar funds

IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
ERWM
Elk River Wealth Management Denver, Colorado $602M AUM 22.77% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
JHCP
Jackson Hole Capital Partners Tulsa, Oklahoma $605M AUM 22.77% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
OCAM
Onex Canada Asset Management Toronto, Ontario, Canada $601M AUM 15.16% 1-Year Est. Return
GP
GSK plc London $599M AUM

Eagle Health Investments's Q1 2022 Portfolio in Review

As of Q1 2022, Eagle Health Investments held 28 positions worth $406M, down 1.1% from $410M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Eagle Health Investments deployed $56.2M of net new capital in Q1 2022, adding to 11 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was AstraZeneca, an estimated $9.95M trimmed.

  • Eagle Health Investments added most to Seagen Inc. Common Stock in Q1 2022, an estimated $20.3M increase.
  • Eagle Health Investments's biggest Q1 2022 reduction was AstraZeneca, cutting an estimated $9.95M.
  • Eagle Health Investments's ten largest holdings make up 63% of its $406M portfolio in Q1 2022.
  • Eagle Health Investments opened 0 new positions and closed 0 in Q1 2022.
  • Eagle Health Investments's portfolio value fell 1.1% quarter-over-quarter to $406M.

Based on Eagle Health Investments's 13F filing for Q1 2022, filed 12 May 2022.